Travere Therapeutics Inc.
Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life changing therapies to people living with rare disease. The headquarters is in USA.
Travere Therapeutics Annual Total Revenue for year ending Dec-2022 was 212 million USD and and Net loss for year ending Dec-2022 was -278 million USD.
Travere Therapeutics Annual Total Revenue for year ending Dec-2021 was 227 million USD and and Net loss for year ending Dec-2021 was -180 million USD.
As on 2022, Travere Therapeutics has 462 employees.